Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer

Abstract Background Chemotherapy, the mainstay treatment for metastatic cancer, presents serious side effects due to off-target exposure. In addition to the negative impact on patients’ quality of life, side effects limit the dose that can be administered and thus the efficacy of the drug. Encapsula...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Eva Romaní -Cubells, Samuel Martínez-Erro, Victoria Morales, Ana Chocarro-Calvo, José M. García-Martínez, Raúl Sanz, Custodia García-Jiménez, Rafael A. García-Muñoz
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2024-05-01
Σειρά:	Journal of Nanobiotechnology
Θέματα:	Periodic mesoporous organosilica (PMO) Magnetic mesoporous organosilica drugs (MOD) Drug delivery systems Mitoxantrone Breast cancer treatment Magnetic nanomedicine
Διαθέσιμο Online:	https://doi.org/10.1186/s12951-024-02522-4
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!